NCT03925571

Brief Summary

The main purpose of MUSANX study is to highlight analgesic effectiveness of musicotherapy in post-surgical periodontal and implant; and to measure its per-operative anxiolytic effectiveness

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
67

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 8, 2019

Completed
16 days until next milestone

First Posted

Study publicly available on registry

April 24, 2019

Completed
9 days until next milestone

Study Start

First participant enrolled

May 3, 2019

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 3, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 3, 2021

Completed
Last Updated

October 4, 2021

Status Verified

October 1, 2021

Enrollment Period

2 years

First QC Date

April 8, 2019

Last Update Submit

October 1, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain intensity

    the pain intensity will be measured with the Visual analogue scale (VAS).

    24 hours after the dental surgery

Secondary Outcomes (1)

  • Efficacy of musicotherapy

    24, 48 and 72 hours

Study Arms (2)

music-listening group

EXPERIMENTAL

patient will listen to music during the dental surgery (1 to 1h30 hours).

Other: musicotherapy

non music-listening group

NO INTERVENTION

patient will receive their dental intervention without music-listening.

Interventions

If the patient is randomized in the experimental group, he listens the Music-care® playlists and chose two closed to his musical tastes. The playlists are unique compositions create by Music-care® (french company), not known from the general public, categorized by theme (jazz, rock, world music…).

music-listening group

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Majors aged between 18 and 55 years, with an appropriate hearing and able to use Music-Care© (selection of the playlist via internet access),
  • Needing treatment in odontology - periodontal surgery (coronary elongation or sanitation surgery or muco-gingival surgery) or implantary surgery (placement of an unit implant or two implant in the same localization),
  • Oral and dated consent,
  • Agreeing to be contacted via phone at J+1 and to fill follow-up study documents,
  • Profiting of social security or CMU.

You may not qualify if:

  • Patients with a long-term taking of anxiolytic or analgesic,
  • Regular consumer of soft drug (cannabis) or hard drug (opioid),
  • Patient with medical history of psychiatry (mental harm), hearing problem, cognitive and behavioural impairment (claustrophobia), sensory disabilities,
  • Patient with problems of hemostasis,
  • Majors under trusteeship or guardianship,
  • Pregnant women or lactating,
  • Minors,
  • Protected person, deprived of freedom or under justice safeguard,
  • Profiting of a medical help from government (AME),
  • Not contactable after care,
  • Patient with hepatic impairment,
  • Patient with dry mouth,
  • Patient relevant a suboptimal hearing incompatible with musicotherapy or inability to use Music-care®.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nantes University Hospital

Nantes, 44093, France

Location

MeSH Terms

Conditions

ToothacheSensation Disorders

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic DiseasesFacial PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsNervous System Diseases

Study Officials

  • Assem Soueidan, Pr

    Nantes University Hospital

    STUDY CHAIR
  • Olivier Bonnot, Pr

    Nantes University Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 8, 2019

First Posted

April 24, 2019

Study Start

May 3, 2019

Primary Completion

May 3, 2021

Study Completion

May 3, 2021

Last Updated

October 4, 2021

Record last verified: 2021-10

Locations